Shoichi Nakazuru

Summary

Affiliation: Osaka National Hospital
Country: Japan

Publications

  1. pmc Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report
    Shoichi Nakazuru
    Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital, Chuo Ku, Osaka City, Osaka 540 0006, Japan
    World J Gastroenterol 16:3853-6. 2010
  2. ncbi request reprint [Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy]
    Hiroko Hasegawa
    Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital, Japan
    Nihon Shokakibyo Gakkai Zasshi 107:1956-62. 2010
  3. ncbi request reprint [Synchronous double cancer of the gallbladder and rectum successfully treated with S-1 as second-line chemotherapy- a case report]
    Manabu Araki
    Dept of Gastroenterology and Hepatology, Osaka National Hospital, Japan
    Gan To Kagaku Ryoho 38:1857-9. 2011
  4. ncbi request reprint Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastasis: symptom/tumor marker-based versus CT-based
    Hiroko Hasegawa
    Department of Gastroenterology, Osaka National Hospital, Osaka, Japan
    Anticancer Res 34:5169-74. 2014
  5. doi request reprint A case report of a duodenal adenocarcinoma: a complication with Crohn's disease
    Yuko Sakakibara
    Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital
    Nihon Shokakibyo Gakkai Zasshi 113:441-50. 2016
  6. doi request reprint Optimal indications for second-line chemotherapy in advanced gastric cancer
    Hiroko Hasegawa
    Departments of Gastroenterology, Osaka National Hospital, Osaka, Japan
    Anticancer Drugs 23:465-70. 2012
  7. doi request reprint Squamous cell carcinoma of the anal canal treated with chemoradiotherapy in a patient with HIV
    Aya Sugimoto
    Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital
    Nihon Shokakibyo Gakkai Zasshi 113:254-62. 2016

Collaborators

  • Motohiro Hirao
  • Kiyoshi Mori
  • Kazumasa Fujitani
  • Hiroko Hasegawa
  • Eiji Mita
  • Yuko Sakakibara
  • Manabu Araki
  • Hisashi Ishida
  • Aya Sugimoto
  • Takuya Yamada
  • Toshimasa Tsujinaka
  • Mari Itoh
  • Noriyoshi Kuzushita
  • Shigeki Suemura
  • Toshiyuki Yoshio
  • Takashi Toyama
  • Tomoko Uehira
  • Akio Ishihara
  • Kumiko Nishio
  • Keiichi Kimura
  • Yoshinori Kodama
  • Keishiro Yajima
  • Tetsuya Iwasaki
  • Ryuichirou Iwasaki
  • Kazuyoshi Yamamoto
  • Yuka Sueyoshi
  • Makiyo Ota
  • Takashi Ohta
  • Kaori Tatsumi
  • Chiaki Mitsuta
  • Makiyo Ohta
  • Chiaki Yoshioka
  • Yoshihiro Ikura

Detail Information

Publications7

  1. pmc Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report
    Shoichi Nakazuru
    Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital, Chuo Ku, Osaka City, Osaka 540 0006, Japan
    World J Gastroenterol 16:3853-6. 2010
    ..Gemcitabine could be an effective treatment option for pancreatic PDEC that is resistant to other treatments...
  2. ncbi request reprint [Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy]
    Hiroko Hasegawa
    Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital, Japan
    Nihon Shokakibyo Gakkai Zasshi 107:1956-62. 2010
    ..Serum levels of NSE and the tumor size were decreased after the first course of CTX. We here report a case of primary hepatic neuroendocrine carcinoma treated with CTX following the diagnosis by the needle biopsy...
  3. ncbi request reprint [Synchronous double cancer of the gallbladder and rectum successfully treated with S-1 as second-line chemotherapy- a case report]
    Manabu Araki
    Dept of Gastroenterology and Hepatology, Osaka National Hospital, Japan
    Gan To Kagaku Ryoho 38:1857-9. 2011
    ..He survived for 17 months after the first course of chemotherapy, and the progression-free survival with S-1 was 10 months. Therefore, S-1 could be an effective agent for synchronous double cancer of the gallbladder and rectum...
  4. ncbi request reprint Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastasis: symptom/tumor marker-based versus CT-based
    Hiroko Hasegawa
    Department of Gastroenterology, Osaka National Hospital, Osaka, Japan
    Anticancer Res 34:5169-74. 2014
    ..We attempted to clarify which criterion for treatment change contributes more to longer survival...
  5. doi request reprint A case report of a duodenal adenocarcinoma: a complication with Crohn's disease
    Yuko Sakakibara
    Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital
    Nihon Shokakibyo Gakkai Zasshi 113:441-50. 2016
    ..Early diagnosis of cases of CD-associated cancers is necessary. We report the features of a rare and illustrative case of duodenal adenocarcinoma in a patient with CD. ..
  6. doi request reprint Optimal indications for second-line chemotherapy in advanced gastric cancer
    Hiroko Hasegawa
    Departments of Gastroenterology, Osaka National Hospital, Osaka, Japan
    Anticancer Drugs 23:465-70. 2012
    ..5 g/dl at initiation of second-line chemotherapy and time to progression less than 170 days on first-line chemotherapy...
  7. doi request reprint Squamous cell carcinoma of the anal canal treated with chemoradiotherapy in a patient with HIV
    Aya Sugimoto
    Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital
    Nihon Shokakibyo Gakkai Zasshi 113:254-62. 2016
    ..The patient is living with no signs of recurrence at 2 years after chemoradiotherapy. When treating HIV-infected patients with anal cancer by chemoradiotherapy and ART, clinicians should be aware of the possibility of CD4 suppression. ..